Form 8-K
8-K — Integer Holdings Corp
Accession: 0000950103-26-015975
Filed: 2026-10-21
Period: 2026-10-21
CIK: 0001114483
SIC: 3845 (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS)
Item: Submission of Matters to a Vote of Security Holders
Item: Regulation FD Disclosure
Item: Financial Statements and Exhibits
Documents
8-K — dp255254_8k.htm (Primary)
EX-99.1 — EXHIBIT 99.1 (dp255254_ex9901.htm)
GRAPHIC (image_001.jpg)
GRAPHIC (image_002.jpg)
GRAPHIC (image_003.jpg)
XML — IDEA: XBRL DOCUMENT (R1.htm)
8-K — FORM 8-K
8-K (Primary)
Filename: dp255254_8k.htm · Sequence: 1
false
0001114483
0001114483
2026-10-21
2026-10-21
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________
FORM 8-K
____________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
October 21, 2026
INTEGER HOLDINGS CORPORATION
(Exact name of registrant as specified in its charter)
____________________________
Delaware
1-16137
16-1531026
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
5830 Granite Parkway,
Suite 1150
Plano, Texas
75024
(Address of principal executive offices)
(Zip Code)
(214) 618-5243
Registrant’s telephone number, including area code
____________________________
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.001 par value per share
ITGR
New York Stock Exchange
Indicate by check mark whether the registrant is an
emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ☐
Item 5.07 Submission of Matters to a Vote of Security Holders.
On October 21, 2026, Integer Holdings Corporation, a Delaware corporation
(“ITGR” or the “Company”), held a special meeting of its stockholders (the “Special Meeting”) to consider
and vote on proposals related to the Agreement and Plan of Merger (the “Merger Agreement,” and the transactions contemplated
thereby, the “Transaction”), dated as of August 2, 2026, by and among the Company, Armstrong Parent, Inc., a Delaware corporation
(“Parent”), and Armstrong Bidco, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”).
Pursuant to the Merger Agreement, and upon the terms and subject to the conditions therein, Merger Sub will merge with and into the Company
(the “Merger”), with the Company surviving the Merger as a wholly owned subsidiary of Parent. Parent and Merger Sub are each
affiliates of investment funds managed by Kohlberg Kravis Roberts & Co. L.P., a leading global investment firm.
As of the close of business on September 8, 2026, the record date for
determining the stockholders entitled to notice of, and to vote at, the Special Meeting, there were 33,997,068 shares of common stock,
par value $0.001 per share, of the Company (“ITGR Common Stock”) outstanding, each of which entitled the holder thereof to
one vote, virtually or by proxy, for each proposal duly brought before the Special Meeting. A total of 26,077,841 shares of ITGR Common Stock,
representing approximately 76.70% of the issued and outstanding shares of ITGR Common Stock entitled to vote at the Special Meeting, were
present virtually or by proxy at the Special Meeting, constituting a quorum to conduct business.
At the Special Meeting, the following proposals were considered:
1. A proposal to adopt the Merger Agreement and the Merger (the “First Proposal”).
The First Proposal was approved by the requisite vote of the Company’s
stockholders. The final voting results for the First Proposal are described below. For more information on the First Proposal, see the
Definitive Proxy Statement filed by the Company with the U.S. Securities and Exchange Commission (the “SEC”) on September
14, 2026 and mailed to the Company’s stockholders on or about September 14, 2026 (the “Proxy Statement”).
1. The First Proposal:
For
Against
Abstain
26,065,335
10,513
1,993
2. A proposal to approve, on an advisory (non-binding) basis, the compensation that will or may be paid or become payable by the Company
to its named executive officers that is based on or otherwise relates to the Transaction as contemplated in the Merger Agreement (the
“Second Proposal”).
The Second Proposal was approved by the requisite vote of the Company’s
stockholders. The final voting results for the Second Proposal are described below. For more information on the Second Proposal, see the
Proxy Statement.
2. The Second Proposal:
For
Against
Abstain
23,859,897
2,172,522
45,422
3. A proposal to approve the adjournment of the Special Meeting to a later date, if necessary or appropriate, to solicit additional proxies
if there are not sufficient votes to approve the First Proposal (the “Third Proposal”).
The Third Proposal was not voted on because the adjournment of the
Special Meeting to solicit additional proxies was not necessary. For more information on the Third Proposal, see the Proxy Statement.
Item 7.01 Regulation FD Disclosure.
On October 21, 2026, the Company issued a press release announcing
that the stockholder approval required in connection with the Transaction has been obtained and that the Transaction is expected to close
by the end of 2026 subject to the satisfaction or waiver of customary closing conditions. A copy of the press release is attached hereto
as Exhibit 99.1 and is incorporated herein by reference.
In accordance with General Instruction B.2 to Form 8-K, the information
provided under this Item 7.01 and the information attached to this Current Report on Form 8-K as Exhibit 99.1 shall be deemed to be “furnished”
and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under
the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act except as expressly set forth by specific
reference in such filing. The furnishing of the information in this report is not intended to, and does not, constitute a determination
or admission by the Company that the information in this report is material or complete, or that investors should consider this information
before making an investment decision with respect to any security of the Company or any of its affiliates.
Cautionary Statement Regarding Forward-Looking Statements
Some of the statements contained in this Current Report and other written
and oral statements made from time to time by us and our representatives are not statements of historical or current fact. As such, they
are “forward-looking statements” within the meaning of Section 27A of the Securities Act, and Section 21E of the Exchange
Act, and are subject to the safe harbor created thereby under the Private Securities Litigation Reform Act of 1995. We have based these
forward-looking statements on our current expectations, and these statements are subject to known and unknown risks, uncertainties and
assumptions. Forward-looking statements include, but are not limited to, statements relating to: the completion of the Transaction on
anticipated terms and timing, or at all, including obtaining regulatory approvals and satisfying other conditions to the completion of
the Transaction; potential litigation relating to the Transaction that could be instituted against the parties to the Merger Agreement
or their respective directors, managers, or officers, including the effects of any outcomes related thereto; our goals, plans, and strategic
initiatives; long-term growth prospects; maximizing value for our stockholders; and other events, conditions or developments that will
or may occur in the future; and timing of any of the foregoing. You can identify forward-looking statements by terminology such as “may,”
“will,” “should,” “could,” “expects,” “intends,” “plans,” “anticipates,”
“believes,” “estimates,” “predicts,” “projects,” “forecast,” “outlook,”
“assume,” “potential” or “continue” or variations or the negative counterparts of these terms or other
comparable terminology. These statements are only predictions and are no guarantee of future performance, and investors should not place
undue reliance on forward-looking statements as predictive of future results. Actual events or results may differ materially from those
stated or implied by these forward-looking statements. In evaluating these statements and our prospects, you should carefully consider
the factors set forth below. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified
in their entirety by these cautionary factors and to others contained throughout this communication.
Forward-looking statements by their nature address matters that are,
to different degrees, uncertain, such as statements regarding the Transaction. All such forward-looking statements are based upon current
plans, estimates, expectations, opportunities and ambitions that are subject to risks, uncertainties, assumptions, and other important
factors, many of which are beyond the control of the Company, that could cause actual results to differ materially from those expressed
in such forward-looking statements. Key factors that could cause actual results to differ materially include, but are not limited to,
the expected timing and likelihood of completion of the Transaction, including the timing, receipt and terms and conditions of any required
governmental and regulatory approvals; the occurrence of any event, change or other circumstances that could give rise to the termination
of the Transaction; the risk that the parties may not be able to satisfy the conditions to the Transaction in a timely manner or at all;
risks related to disruption of management time from ongoing business operations due to the Transaction; the risk that any announcements
relating to the Transaction could have adverse effects on the market price of the Company’s common stock; the risk that the Transaction
and its announcement could have an adverse effect on the parties’ business relationships and business generally, including the ability
of the Company to retain customers and retain and hire key personnel and maintain relationships with their suppliers and customers, and
on their operating results and businesses generally; the risk of unforeseen or unknown liabilities; customer, regulatory and other stakeholder
approvals and support; the risk of unexpected future capital expenditures; the risk of potential litigation relating to the Transaction
that could be instituted against the Company or its directors and/or officers; the risk associated with third-party contracts containing
material consent, anti-assignment, transfer or other provisions that may be related to the Transaction which are not waived or otherwise
satisfactorily resolved; significant costs, or expenses incurred in connection with the Transaction; Parent’s ability to obtain
the necessary financing arrangements set forth in the commitment letters received in connection with the Transaction; certain restrictions
contained in the Merger Agreement that may impact the Company’s ability to pursue certain business opportunities or strategic transactions;
the risk of various events that could disrupt operations, including pandemics, epidemics or other public health crises or severe weather
(such as droughts, floods, avalanches and earthquakes), cybersecurity attacks, security threats and governmental response to them, and
technological changes; the risks of labor disputes, changes in labor costs and labor difficulties; and the risks resulting from other
effects of industry, market, economic, legal or legislative, political or regulatory conditions outside of the Company’s control.
All such factors are difficult to predict and are beyond our control, including those detailed in the Company’s annual report on
Form 10-K for the fiscal year ended December 31, 2025, which was filed with the SEC on February 23, 2026, the Company’s quarterly
report on Form 10-Q for the fiscal quarter ended July 3, 2026, which was filed with the SEC on August 4, 2026 and other documents subsequently
filed by the Company with the SEC. The Company’s forward-looking statements are based on assumptions that the Company believes to
be reasonable but that may not prove to be accurate. Other unpredictable factors not discussed in this communication could also have material
adverse effects on forward-looking statements. The Company does not assume an obligation to update any forward-looking statements, except
as required by applicable law. These forward-looking statements speak only as of the date hereof.
Item 9.01 Financial Statements and Exhibits.
Exhibit No.
Exhibit
99.1
Press release issued by Integer Holdings Corporation on October 21, 2026
104
Cover Page Interactive Data File (embedded within the inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: October 21, 2026
/s/
Lindsay K. Blackwood
Name: Lindsay K. Blackwood
Title: General Counsel and Corporate Secretary
EX-99.1 — EXHIBIT 99.1
EX-99.1
Filename: dp255254_ex9901.htm · Sequence: 2
Exhibit 99.1
Integer Holdings
Corporation Stockholders Approve Proposals in Connection with KKR’s Proposed Acquisition of Integer
PLANO, Texas, October 21, 2026 (GLOBE
NEWSWIRE) – Integer Holdings Corporation (NYSE: ITGR) (“Integer” or the “Company”) and Armstrong Parent,
Inc. (“Parent”) today announced that, in connection with Parent’s proposed acquisition of the Company (the “Transaction”)
contemplated by their Agreement and Plan of Merger, dated as of August 2, 2026 (the “Merger Agreement”), the stockholders
of the Company have voted in favor of (1) the proposal to adopt the Merger Agreement and the Merger (the “First Proposal”)
and (2) the proposal to approve, on an advisory (non-binding) basis, the compensation that will or may be paid or become payable to Integer’s
named executive officers that is based on or otherwise related to the Transaction as contemplated in the Merger Agreement (the “Second
Proposal”) at a special meeting of stockholders held on October 21, 2026 (the “Special Meeting”).
At the Special Meeting, (1) approximately
99.95% of the shares voted on the First Proposal were cast in favor of the First Proposal, representing
approximately 76.66% of the total outstanding shares of Integer
common stock as of the record date, September 8, 2026 (the “Record Date”), and (2) the Second Proposal was approved by a
majority of the votes cast at the Special Meeting. The Company will provide a full report of the voting results from the Special Meeting
in a Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission (the “SEC”).
The Transaction is anticipated to close
by the end of 2026, subject to the satisfaction or waiver of customary closing conditions specified in the Merger Agreement, including
the receipt of required regulatory approvals.
About Integer®
Integer Holdings Corporation (NYSE:
ITGR) is one of the largest medical device contract development and manufacturing organizations (CDMOs) in the world, serving the cardio
and vascular, neuromodulation, and cardiac rhythm management markets. As a strategic partner of choice, we advance the goals of our medical
device customers through industry-leading engineering and manufacturing, with a relentless commitment to quality, service, and innovation.
The Company’s brands include Greatbatch Medical® and Lake Region Medical®. Additional information
is available at www.integer.net.
Contacts
Integer
Media Relations:
Misty Tippen
misty.tippen@integer.net
469-536-6702
Investor Relations:
Kristen Stewart
kristen.stewart@integer.net
551-337-3973
Cautionary Statement
Regarding Forward-Looking Statements
Some of the statements
contained in this communication and other written and oral statements made from time to time by us and our representatives are not statements
of historical or current fact. As such, they are “forward-looking statements” within the meaning of Section 27A of the Securities
Act, and Section 21E of the Exchange Act, and are subject to the safe harbor created thereby under the Private Securities Litigation
Reform Act of 1995. We have based these forward-looking statements on our current expectations, and these statements are subject to known
and unknown risks, uncertainties and assumptions. Forward-looking statements include, but are not limited to, statements relating to:
the completion of the Transaction on anticipated terms and timing, or at all, including obtaining regulatory approvals and satisfying
other conditions to the completion of the Transaction; potential litigation relating to the Transaction that could be instituted against
the parties to the Merger Agreement or their respective directors, managers, or officers, including the effects of any outcomes related
thereto; our goals, plans, and strategic initiatives; long-term growth prospects; maximizing value for our stockholders; and other events,
conditions or developments that will or may occur in the future; and timing of any of the foregoing. You can identify forward-looking
statements by terminology such as “may,” “will,” “should,” “could,” “expects,”
“intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,”
“projects,” “forecast,” “outlook,” “assume,” “potential” or “continue”
or variations or the negative counterparts of these terms or other comparable terminology. These statements are only predictions and
are no guarantee of future performance, and investors should not place undue reliance on forward-looking statements as predictive of
future results. Actual events or results may differ materially from those stated or implied by these forward-looking statements. In evaluating
these statements and our prospects, you should carefully consider the factors set forth below. All forward-looking statements attributable
to us or persons acting on our behalf are expressly qualified in their entirety by these cautionary factors and to others contained throughout
this communication.
Forward-looking
statements by their nature address matters that are, to different degrees, uncertain, such as statements regarding the transactions contemplated
by the Transaction. All such forward-looking statements are based upon current plans, estimates, expectations, opportunities and ambitions
that are subject to risks, uncertainties, assumptions, and other important factors, many of which are beyond the control of the Company,
that could cause actual results to differ materially from those expressed in such forward-looking statements. Key factors that could
cause actual results to differ materially include, but are not limited to, the expected timing and likelihood of completion of the Transaction,
including the timing, receipt and terms and conditions of any required governmental and regulatory approvals; the occurrence of any event,
change or other circumstances that could give rise to the termination of the Transaction; the risk that the parties may not be able to
satisfy the conditions to the Transaction in a timely manner or at all; risks related to disruption of management time from ongoing business
operations due to the Transaction; the risk that any announcements relating to the Transaction could have adverse effects on the market
price of the Company’s common stock; the risk that the Transaction and its announcement could have an adverse effect on the parties’
business relationships and business generally, including the ability of the Company to retain customers and retain and hire key personnel
and maintain relationships with their suppliers and customers, and on their operating results and businesses generally; the risk of unforeseen
or unknown liabilities; customer, regulatory and other stakeholder approvals and support; the
risk of unexpected
future capital expenditures; the risk of potential litigation relating to the Transaction that could be instituted against the Company
or its directors and/or officers; the risk associated with third-party contracts containing material consent, anti-assignment, transfer
or other provisions that may be related to the Transaction which are not waived or otherwise satisfactorily resolved; significant costs,
or expenses incurred in connection with the Transaction; Parent’s ability to obtain the necessary financing arrangements set forth
in the commitment letters received in connection with the Transaction; certain restrictions contained in the Merger Agreement that may
impact the Company’s ability to pursue certain business opportunities or strategic transactions; the risk of various events that
could disrupt operations, including pandemics, epidemics or other public health crises or severe weather (such as droughts, floods, avalanches
and earthquakes), cybersecurity attacks, security threats and governmental response to them, and technological changes; the risks of
labor disputes, changes in labor costs and labor difficulties; and the risks resulting from other effects of industry, market, economic,
legal or legislative, political or regulatory conditions outside of the Company’s control. All such factors are difficult to predict
and are beyond our control, including those detailed in the Company’s annual report on Form 10-K for the fiscal year ended December
31, 2025, which was filed with the SEC on February 23, 2026, the Company’s quarterly report on Form 10-Q for the fiscal quarter
ended July 3, 2026, which was filed with the SEC on August 4, 2026 and other documents subsequently filed by the Company with the SEC.
The Company’s forward-looking statements are based on assumptions that the Company believes to be reasonable but that may not prove
to be accurate. Other unpredictable factors not discussed in this communication could also have material adverse effects on forward-looking
statements. The Company does not assume an obligation to update any forward-looking statements, except as required by applicable law.
These forward-looking statements speak only as of the date hereof.
GRAPHIC
GRAPHIC
Filename: image_001.jpg · Sequence: 3
Binary file (3844 bytes)
Download image_001.jpg
GRAPHIC
GRAPHIC
Filename: image_002.jpg · Sequence: 4
Binary file (1953 bytes)
Download image_002.jpg
GRAPHIC
GRAPHIC
Filename: image_003.jpg · Sequence: 5
Binary file (2372 bytes)
Download image_003.jpg
XML — IDEA: XBRL DOCUMENT
XML
Filename: R1.htm · Sequence: 10
v3.26.3
Cover
Oct. 21, 2026
Cover [Abstract]
Document Type
8-K
Amendment Flag
false
Document Period End Date
Oct. 21, 2026
Entity File Number
1-16137
Entity Registrant Name
INTEGER HOLDINGS CORPORATION
Entity Central Index Key
0001114483
Entity Tax Identification Number
16-1531026
Entity Incorporation, State or Country Code
DE
Entity Address, Address Line One
5830 Granite Parkway
Entity Address, Address Line Two
Suite 1150
Entity Address, City or Town
Plano
Entity Address, State or Province
TX
Entity Address, Postal Zip Code
75024
City Area Code
214
Local Phone Number
618-5243
Written Communications
false
Soliciting Material
false
Pre-commencement Tender Offer
false
Pre-commencement Issuer Tender Offer
false
Title of 12(b) Security
Common Stock, $0.001 par value per share
Trading Symbol
ITGR
Security Exchange Name
NYSE
Entity Emerging Growth Company
false
X
- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details
Name:
dei_AmendmentFlag
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Area code of city
+ References
No definition available.
+ Details
Name:
dei_CityAreaCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Cover page.
+ References
No definition available.
+ Details
Name:
dei_CoverAbstract
Namespace Prefix:
dei_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
No definition available.
+ Details
Name:
dei_DocumentPeriodEndDate
Namespace Prefix:
dei_
Data Type:
xbrli:dateItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details
Name:
dei_DocumentType
Namespace Prefix:
dei_
Data Type:
dei:submissionTypeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine1
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 2 such as Street or Suite number
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine2
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the City or Town
+ References
No definition available.
+ Details
Name:
dei_EntityAddressCityOrTown
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details
Name:
dei_EntityAddressPostalZipCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the state or province.
+ References
No definition available.
+ Details
Name:
dei_EntityAddressStateOrProvince
Namespace Prefix:
dei_
Data Type:
dei:stateOrProvinceItemType
Balance Type:
na
Period Type:
duration
X
- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityCentralIndexKey
Namespace Prefix:
dei_
Data Type:
dei:centralIndexKeyItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityEmergingGrowthCompany
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details
Name:
dei_EntityFileNumber
Namespace Prefix:
dei_
Data Type:
dei:fileNumberItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details
Name:
dei_EntityIncorporationStateCountryCode
Namespace Prefix:
dei_
Data Type:
dei:edgarStateCountryItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityRegistrantName
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityTaxIdentificationNumber
Namespace Prefix:
dei_
Data Type:
dei:employerIdItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Local phone number for entity.
+ References
No definition available.
+ Details
Name:
dei_LocalPhoneNumber
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
+ Details
Name:
dei_PreCommencementIssuerTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
+ Details
Name:
dei_PreCommencementTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details
Name:
dei_Security12bTitle
Namespace Prefix:
dei_
Data Type:
dei:securityTitleItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details
Name:
dei_SecurityExchangeName
Namespace Prefix:
dei_
Data Type:
dei:edgarExchangeCodeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14a
-Subsection 12
+ Details
Name:
dei_SolicitingMaterial
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details
Name:
dei_TradingSymbol
Namespace Prefix:
dei_
Data Type:
dei:tradingSymbolItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
+ Details
Name:
dei_WrittenCommunications
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration